There’s good news today for the more than 30,000 people receiving life-saving kidney transplants globally each year. Carlsbad, California-based Invitrogen aims to improve life after transplant with a new biomarker tool that addresses two chronic and life-threatening challenges: kidney rejection triggered by the graft and the cumulative cell and tissue damage caused by immunosuppressive drugs [...]
As the International Society for Stem Cell Research (ISSCR) kicked off its annual meeting in Barcelona today, stem cell technology start-up iZumi Bio, a recent Fierce 15 finalist, grabbed headlines with the announcement that it had merged with Pierian, another stem cell technology start-up whose founders include three Harvard faculty members.
The newly formed company, called [...]
Network World yesterday broke some really fascinating news out of Japan: namely, that researchers at Toyota (yes, the car manufacturer) and others have developed a brain-machine interface (BMI) system that allows wheelchair-bound patients control of their transportation through their thoughts.
Researchers claim that the system processes brain thought patterns and can translate them into movement in [...]
News about medical imaging seems to be on the rise. As noted in one of our posts last week, Congress recently sent a bipartisan letter to the president urging continued support for policies that promote medical imaging. And this week medical imaging is making headlines again with news of a new biomarker for predicting responses [...]
More imaging news today: as the Obama administration works toward revamping the healthcare system and momentum continues to build, a new bipartisan letter from 57 members of Congress today went to the President expounding on the benefits of medical imaging. Inside, they claimed that each $1 spent on imaging services correlates to approximately $3 in [...]
A Cambridge-based biopharma, developing a revolutionary class of drugs called Stapled Peptides, received some major backing from big pharma today. Fierce Biotech reported that Aileron Therapeutics landed $40 million in Series D funding from the venture arms of four of the world’s biggest pharma companies, including SR One (the corporate venture fund of GlaxoSmithKline), Novartis [...]
More positive news for bio-tech in New England!
Even as the economy shrinks and VC money gets harder to come by, innovation is still be nurtured and rewarded for local life sciences companies. According to Mass High Tech today, Proteon Therapeutics, Inc. has completed a second closing of its Series B equity financing, raising an additional [...]
The 2009 Bio International Convention, which took place in Atlanta last week, was host to a number of educational sessions around biotech innovations, including one that highlighted the need for drawing a closer connection between research and clinical care. As FierceBiotech IT reported, EHRs were at the center of a discussion on “Transforming the Research [...]
Late last week, Massachusetts General Hospital (MGH) announced the development of software that could allow diagnosis of early Alzheimer’s disease. The software program, developed at the Martinos Center for Biomedical Imaging at MGH, differentiates between patients with mild cognitive impairment (a lesser form of dementia that precedes the development of Alzheimer’s by several years) from [...]
What if it was possible to test a new medical device designed for cardiac surgery at a fraction of the cost it usually takes by forgoing the need to first conduct a clinical trial? Scientists at North Carolina State University think they may have figured out a way to do just that with a new [...]